Who
Angela Thedinga
Director
Company insider
Files Form 4 as: Director, Nkarta; Chief Technology Officer, Adverum Biotechnologies.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Feb 2020
- Last trade
- 10 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 11 Jun 2026 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,000 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,218 at $0.00 | filing |
| 28 Mar 2022filed 29 Mar 2022 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 6 Aug 2021filed 10 Aug 2021 | Adverum Biotechnologies | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 6 Aug 2021filed 10 Aug 2021 | Adverum Biotechnologiesoption or derivative | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | Adverum Biotechnologiesoption or derivative | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 21 Feb 2020filed 25 Feb 2020 | Adverum Biotechnologiesoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.